Prevalence of a 32 BP deletion in the gene for human immunodeficiency virus 1 co-receptor CCR5 in Slovak population

Acta Virologica

Volumn 52, Issue 4, 2008, Pages 261-264

  Takacova M ^a   Nogova P ^a   Habekova M ^a   Stanekova D ^a  

^a SLOVAK MEDICAL UNIVERSITY   (Slovakia)

Author keywords

32 mutation; CCR5 co receptor; Human immunodeficiency virus 1; Slovakia

Indexed keywords

CHEMOKINE RECEPTOR CCR5;

ALLELE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE MUTATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; SLOVAKIA;

FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; PREVALENCE; RECEPTORS, CCR5; RECEPTORS, VIRUS; SEQUENCE DELETION; SLOVAKIA;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 58549116505     PISSN: 0001723X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA (1996): CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272, 1955-1958.
2. Beretta A, Quillent C, Siesdedos FA, Braun J (2000) Human immunodeficiency virus co-receptor variants associated with resistance to virus infection. United States Patent, Patent No. 6153431.
3. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikments R, Goedert JJ, Buchbinder SP, Vittinghoff E, Gomperts E, Donfield S, Vlahov D, Kaslow R, Saah A, Rinaldo C, Detels R, O'Brien SJ (1996): Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 273, 1856-1862.
4. Doranz BJ, Rucker J, Yi Y, Smyth RJ, Samson M, Peiper S, Parmentier M, Collman RG, Doms RW (1996): A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85, 1149-1158.
5. Drábek J, Petrek M (1998): 32 bp deletion in CCR-5 gene and human immunodeficiency virus epidemic in the Czech Republic. Acta Virol. 42, 121-122.
6. Gibejová A (2000): Chemokine receptors. Acta Univ. Palacki. Olomuc. Fac. Med. 143, 9-18.
7. Hummel S, Schmidt D, Kremeyer B, Herrmann B, Oppermann M (2005): Detection of the CCR5-Delta32 HIV resistance gene in Bronze Age skeletons. Genes Immun. 6, 371-374.
8. Kozhekbaeva GM, Borodina TA, Borinskaia SA, Gusar VA, Feshchenko SP, Akhmetova VL, Khusainova RI, Gupalo EIu, Spitsyn VA, Grechanina EIa, Khusnutdinova K, Iankovskii NK (2004): Distribution of the HIV-1 resistance-conferring alleles (CCR5delta32, CCR2-64l, and SDF1 3′A) in Russian, Ukrainian, and Belarusian populations. Genetika 40, 1394-1401.
9. Kremeyer B, Hummel S, Herrmann B (2005): Frequency analysis of the delta32ccr5 HIV resistnce allele in a medieval plaque mass grave. Anthropol. Anz. 63, 13-22.
10. Libert F, Cochaux P, Beckman G, Samson M, Aksenova M, Cao A, Czeizel A, Claustres M, de la Rua C, Ferrari M, Ferrec C, Glover G, Grinde B, Guran S, Kucinskas V, Lavinha J, Mercier B, Ogur G, Peltonen L, Rosatelli C, Schwartz M, Spitsyn V, Timar L, Beckman L, Parmentier M, Vassart G (1998): The deltaccr5 mutation conferrning protection against HIV-1 in Caucasian populations has a single and recent origin in Northeastern Europe. Hum. Mol. Genet. 7, 399-406.
11. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, MacDonald ME, Stuhlmann H, Koup RA, Landau NR (1996): Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86, 367-377.
12. Lu Y, Nerurkar VR, Dashwood WM, Woodward CL, Ablan S, Shikuma CM, Grandinetti A, Chang H, Nguyen HT, Wu Z, Yamamura Y, Boto WO, Merriwether A, Kurata T, Detels R, Yanagihara R (1999): Genotype and allele frequency of a 32-base pair deletion mutation in the CCR5 gene in various ethnic groups: absence of mutation among Asians and Pacific Islanders. Int. J. Infect. Dis. 3, 186-191.
13. Lucotte G (2001): Distribution of the CCR5 Gene 32-Basepair Deletion in West Europe. A Hypothesis About the Possible Dispersion of the Mutation by the Vikings in Historical Times. Hum. Immunol. 62, 933-936.
14. Marmor M, Sheppard HW, Donnell D, Bozeman S, Celum C, Buchbinder S, Koblin B, Seage GR 3rd; HIV Network for Prevention Trials Vaccine Preparedness Protocol Team (2001): Homozygous and heterozygous CCR5-Delta32 genotypes are associated with resistance to HIV infection. J. Acquir. Immune Defic. Syndr. 27, 472-481.
15. Oh DY, Jessen H, Kucherer C, Neumann K, Oh N, Poggensee G, Bartmeyer B, Jessen A, Pruss A, Schumann RR, Hamouda O (2008): CCR5Delta32 genotypes in a German HIV-1 seroconverter cohort and report of HIV-1 infection in a CCR5Delta32 homozygous individual. PLoS ONE 3, e2747.
16. Piasecki E, Rybka K, Zwolinska K, Knysz B, Gasiorowski J, Gladysz A (2005): CCR5 polymorphism as potent factor affecting susceptibility to HIV-1 infection in Polish population. 15th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Copenhagen, pp. 135.
17. Roman F, Franck N, Burgy C, Servais J, Zimmer JM, Mossong J, Goubau P, Schneider F, Hemmer R, Schmit JC (2002): Prevalence of HIV co-receptor polymorphism in HIV-infected patients and uninfected volunteers in Luxembourg. HIV Clin. Trials 3, 195-201.
18. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, Saragosti S, Lapoumeroulie C, Cognaux J, Forceille C, Muyldermans G, Verhofstede C, Burtonboy G, Georges M, Imai T, Rana S, Yi Y, Smyth RJ, Collman RG, Doms RW, Vassart G, Parmentier M (1996a): Resistence to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382, 722-725.
19. Samson M, Soularue P, Vassart G, Parmentier M (1996b): The genes encoding the human CC-chemokine receptors CC-CKR1 to CC-CKR5 (CMKBR1-CMKBR5) are clustered in the p21.3-p24 region of chromosome 3. Genomics 36, 522-526.
20. Sattentau QJ, Weiss RA (1988): The CD4 antigen: physiological ligand and HIV receptor. Cell 52, 631-633.
21. Wasik TJ, Smolen J, Kruszynski P, Bratosiewicz-Wasik J, Beniowski M (2005): Effects of CCR5-delta32, CCR2-64I and SDF-1-3′A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population. Wiad Lek. 58, 500-507.